Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (Core) Mutant SL3-3 Murine Leukemia Virus by a Second-Site Enhancer Variant Evolved in Vivo.
Journal of Virology - United States
doi 10.1128/jvi.71.10.7273-7280.1997
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1997
Authors
Publisher
American Society for Microbiology